3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia
1
Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Biphenotypic, Acute
1
Hematologic Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Down Syndrome
1
Interventions
pembrolizumab
18
Specimen Handling
16
Magnetic Resonance Spectroscopy
11
Biopsy
11
Paclitaxel
8
Carboplatin
8
trastuzumab deruxtecan
6
Pemetrexed
6
Nivolumab
6
Irinotecan
6
Fulvestrant
6
Bevacizumab
6
Radiosurgery
5
Leucovorin
5
Gemcitabine
5
Fluorouracil
5
Cetuximab
5
palbociclib
4
Oxaliplatin
4
Letrozole
4
Cisplatin
4
olaparib
3
durvalumab
3
Taxes
3
Ipilimumab
3
Docetaxel
3
Capecitabine
3
130-nm albumin-bound paclitaxel
3
sacituzumab govitecan
2
ribociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Methylprednisolone
×
30 days
×
Clear all
No trials found.